The NIH Office of Technology Transfer (OTT) evaluates, protects, monitors, and manages the NIH invention portfolio to carry out the mandates of the Federal Technology Transfer Act of 1986. This is largely accomplished through overseeing patent prosecution, negotiating and monitoring licensing agreements, and providing oversight and central policy review of Cooperative Research and Development Agreements. OTT also manages the patent and licensing activities for the Food and Drug Adminstration (FDA). OTT is responsible for the central development and implementation of technology transfer policies for four research components of the PHS — the NIH, the FDA, and the Centers for Disease Control and Prevention, and the Agency for Healthcare Research and Quality.
Please feel free to contact us if you have any questions or would like additional information regarding PHS technology development and licensing.
|
||||||||||||||||||||||
|
||||||||||||||||||||||
